Temporary source issue: live-price. Available sections remain usable while the affected layer retries on a later request.
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Reported and computed values remain separate; missing values are not converted to zero.
Research path: Interpret B&B Triplewall Containers's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
Calculated from validated daily candles. Descriptive research only.
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 439.38 | 423.02 | 376.86 |
| Cash Equivalents | 1.19 | Not available | Not available |
| Other Liabilities Total | 1.18 | 0.76 | 0.62 |
| Accrued Expenses | 0 | 0 | 0 |
| Long Term Debt | 106.02 | 125.95 | 129.34 |
| Common Stock Total | 20.51 | 20.51 | 20.51 |
| Other Equity Total | 0 | -0.08 | -0.08 |
| Other Current Assets Total | 18.07 | 1.05 | 0.71 |
| Total Assets | 439.38 | 423.02 | 376.86 |
| Current Portof LT Debt/Capital Leases | 4.26 | 16.68 | 17.86 |
| Cash | 0.59 | 0.52 | 0.18 |
| Total Equity | 132.09 | 111.43 | 119.01 |
| Long Term Investments | 5.43 | 0.67 | 0.71 |
| Retained Earnings(Accumulated Deficit) | 111.58 | 70.13 | 77.72 |
| Total Common Shares Outstanding | 2.05 | 2.05 | 2.05 |
| Tangible Book Valueper Share Common Eq | 64.19 | 54.07 | 57.85 |
| Total Liabilities | 307.29 | 311.59 | 257.85 |
| Total Debt | 251.04 | 239.81 | 202.68 |
| Short Term Investments | 0.93 | Not available | Not available |
| Cashand Short Term Investments | 2.71 | 0.52 | 0.18 |
| Total Receivables Net | 99.22 | 92.43 | 82.13 |
| Notes Payable/Short Term Debt | 124.78 | 85.92 | 44.24 |
| Accounts Receivable-Trade Net | 99.22 | 87.3 | 78.88 |
| Property/Plant/Equipment Total-Net | 214.43 | 237.95 | 228.21 |
| Minority Interest | -1.95 | -1.01 | -0.43 |
| Total Current Liabilities | 186.06 | 174.63 | 117.09 |
| Total Inventory | 95.57 | 81.43 | 53.61 |
| Accounts Payable | 41.07 | 53.6 | 41.17 |
| Other Currentliabilities Total | 15.94 | 18.43 | 13.82 |
| Total Long Term Debt | 122 | 137.21 | 140.57 |
| Intangibles Net | 0.44 | 0.51 | 0.36 |
| Other Long Term Assets Total | 3.51 | 4.62 | 2.54 |
| Total Current Assets | 215.58 | 176.48 | 137.75 |
| Capital Lease Obligations | 15.98 | 11.26 | 11.23 |
| Accumulated Depreciation Total | Not available | -101.55 | -71.11 |
| Prepaid Expenses | Not available | 1.04 | 1.11 |
| Additional Paid-In Capital | Not available | 20.86 | 20.86 |
| Property/Plant/Equipment Total-Gross | Not available | 339.34 | 149.46 |
| Deferred Income Tax | Not available | 0 | 0 |
| Note Receivable-Long Term | Not available | 2.79 | 7.29 |
PEG Ratio1.91
Price to Sale Ratio0.70
Debt 5Yr CAGR %38.89
Operating Margin 12m7.78
Operating Margin 5y Avg7.18
Net Profit Margin 12m3.2
Net Profit Margin 5y3.39
Dividend Yield %0
Overall RiskHigh risk
Board Risk59.57
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| EPL | INR 234.05 | 7,485.4 | 18.64 | — |
| AGI Greenpac | INR 674.55 | 4,361.61 | 12.67 | — |
| Uflex | INR 504.7 | 3,658.08 | 9.5 | — |
| TCPL Packaging | INR 3,339.2 | 2,987.83 | 27.26 | — |
| Mold-Tek Packaging | INR 710 | 2,359.26 | 31.99 | — |
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Olverembatinib Plus Blinatumomab Yields High Early-Phase CR/CRi Rates in R/R Ph+ CML and B-ALL OncLive
As Jewish Nevadans, Tisha B’Av calls us to remember. Recent events call us to act. Nevada Current
Northrop Grumman raises 2026 outlook as backlog hits record $105B (NOC:NYSE) Seeking Alpha
Robinhood Chain nears $9B DEX volume within weeks of launch: FalconX report Crypto News
Opinion: The FDA’s 505(b)(2) pathway is an underestimated engine of value creation BioSpace
Abu Dhabi National Oil Company invests in $6.2B domestic gas project Semafor
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
B&B Triplewall Containers Limited is an India-based company, which is engaged in the manufacturing and sale of corrugated boards and boxes. The Company's product categories include corrugated boards, corrugated boxes, corrugated rolls and custom packaging. Its custom packaging solutions include a range of features, such as printing, labeling, inserts, and special coatings or sizes. It specializes in providing custom packaging solutions that meet the specific needs of its clients. It creates custom packaging in a variety of materials, including corrugated boxes, paperboard, and plastic. Corrugated boards are widely used in the packaging industry for a variety of products, including food, beverages, electronics and household goods. It has an installed capacity of 5000 tons/ month, within a single facility and a combined installed capacity of 9300 tons/ month from all its facilities. Corrugated rolls are widely used in the packaging and shipping industry for a variety of products.
B&B Triplewall Containers has the symbol BBTCL and ISIN - INE01EE01011.
B&B Triplewall Containers is currently trading at INR 224.00.
B&B Triplewall Containers has a year high of INR 262.00 and a year low of INR 156.00.
B&B Triplewall Containers has a market capitalization of INR 434.33 crore.
B&B Triplewall Containers has a P/E ratio of 6.84.
B&B Triplewall Containers has a dividend yield of 0.00%.
B&B Triplewall Containers has revenue of INR 616.35 crore, net income of INR 20.64 crore, and EPS of INR 23.35.
B&B Triplewall Containers has a book value of INR 64.19.
B&B Triplewall Containers has a debt-to-equity ratio of NA.
B&B Triplewall Containers has a price-to-book ratio of 3.49 and a price-to-sales ratio of 0.70.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.